PROCEDURAL STEPS TAKEN AFTER GRANTING THE MARKETING 
AUTHORISATION 
For procedures finalised after 1 February 2004, please refer to module 8B.  
Scope 
Application 
number 
Type of 
modification1 
Update of or change(s) to the pharmaceutical documentation and 
Change(s) to the manufacturing process for the active substance 
Update of Summary of Product Characteristics and Package Leaflet 
Change(s) to the manufacturing process for the active substance 
II/01 
II/02 
II/03 
II 
II 
II 
Notification/ 
Opinion 
issued on2 
22.05.03 
20.11.03 
17.12.03 
Commission 
Decision 
Issued/amended 
on 
02.06.03 
29.01.04 
15.01.04 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers 
to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a 
minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an 
Annex II application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) 
No 2141/96 of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 
March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification 
date. The Commission Decision will be amended accordingly. 
1/1 
   ï£©EMEA 2004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                      
 
